Animal health company Zoetis Inc. (NYSE:ZTS) traded higher Friday as analysts commented on the FDA approval of German drugmaker Boehringer Ingelheim's parasiticide NexGard Plus for dogs. The treatment ...
NexGard SPECTRA has launched its latest campaign via Ward6, part of The Ward Marketing Group, and Boehringer Ingelheim to spotlight parasite protection for cats and dogs. Tasked with localising the ...
- New beef flavored chew builds on success of NexGard® for fleas and ticks with added prevention of heartworm disease and treatment of intestinal worms in dogs - Paris, France – January 19, 2015 – ...
The product features a triple action formula that includes esafoxolaner – the newly developed form of afoxolaner - combined with eprinomectin and praziquantel. This innovative broad spectrum topical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback